Page last updated: 2024-10-27

fenoldopam and Renal Artery Stenosis

fenoldopam has been researched along with Renal Artery Stenosis in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Research Excerpts

ExcerptRelevanceReference
"The present studies were conducted to: a) comparatively evaluate the effects of clevidipine, a new dihydropyridine calcium antagonist, and fenoldopam, a dopamine (D-1) receptor agonist on basal renal function, and b) to determine the efficacy of these agents in protecting renal function in an experimental model of ischemia/reperfusion (I/R) induced acute renal failure in rats."3.71Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. ( Jandhyala, BS; Stephens, CT, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stephens, CT1
Jandhyala, BS1

Other Studies

1 other study available for fenoldopam and Renal Artery Stenosis

ArticleYear
Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2002, Volume: 24, Issue:4

    Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Dopamine Agonists; Fenoldopam; Glomerular Filt

2002